Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	Sample type	Gender
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	126	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	433	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	740	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	786	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	918	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	944	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	971	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1005	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1037	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1045	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1125	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1236	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1311	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1354	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1359	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1382	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1409	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1417	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1437	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1455	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1483	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1486	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1489	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1498	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1502	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1566	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1571	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1598	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1606	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1615	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1623	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1631	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1691	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1709	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1723	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1753	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1774	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1787	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1797	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1803	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1808	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1846	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1854	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1861	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1895	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1914	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1922	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1929	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1931	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	1962	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2003	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2005	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2058	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2079	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2097	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2112	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2113	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2124	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2125	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2130	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2148	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2155	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2177	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2179	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2183	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2222	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2224	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2224	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2227	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2228	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2230	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2231	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2232	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2238	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2244	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2249	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2266	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2272	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2272	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2280	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2295	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2297	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2299	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2317	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2320	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2323	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2324	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2330	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2331	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2336	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2338	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2341	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2346	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2353	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2353	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2354	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2355	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2358	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2362	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2363	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2363	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2369	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2374	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2385	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2390	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2393	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2395	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2396	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2397	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2404	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2405	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2415	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2420	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2421	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2421	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2425	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2425	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2427	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2445	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2450	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2452	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2474	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2476	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2479	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2480	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2484	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2485	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2498	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2514	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2523	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2553	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2564	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2565	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2579	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2587	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2613	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2625	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2630	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2636	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2643	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2656	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2669	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2685	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2687	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2708	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2715	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2724	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2732	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2740	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2744	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2750	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2761	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2767	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2776	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2792	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2795	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2799	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2800	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2822	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2839	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2844	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2844	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2869	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2894	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2901	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2905	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2931	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2964	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2984	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	2999	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3008	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3028	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3044	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3094	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3110	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3116	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3119	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3123	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3145	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3149	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3152	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3159	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3210	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3216	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3223	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3243	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3271	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3280	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3286	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3297	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3311	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3336	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3339	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3364	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3377	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3385	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3388	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3428	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3430	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	N-acetylleucine	3452	Peak area normalized	Sample	male

Return to search page